Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessandra Giustozzi
Institution:
Università Cattolica del Sacro Cuore
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0004-1290-3087
Observed ORCID:
0009-0004-1290-3087
OpenAlex ID:
A5047170845
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives
2021
·
Alessandra Giustozzi
, Vanda Salutari
, et al.
·
Biology
·
15
PDF
Advances in treatment strategies for low-grade serous ovarian cancer
2025
·
Lucia Musacchio
, Domenica Lorusso
, et al.
·
Cancer Treatment Reviews
·
6
ENDOESTRO score: Where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective study
2025
·
Emanuele Perrone
, Ettore Distefano
, et al.
·
European Journal of Cancer
·
6
Immune checkpoint inhibitors in platinum-resistant ovarian cancer: Clinical disappointments, biological lessons, and the reopening of therapeutic opportunities
2026
·
Elena Giudice
, Andrea Spinazzola
, et al.
·
Cancer Treatment Reviews
ENDOESTRO-Score: Where Is The Dark Side? Evaluation Of Estrogen Receptor Expression Cut-Off In Endometrial Cancer Molecular Classification, A Retrospective Study
2025
·
Emanuele Perrone
, Ettore Distefano
, et al.
·
International Journal of Gynecological Cancer
Time To Second Progression Of Bevacizumab Versus PARP Inhibitors As Maintenance Therapy After First-Line Platinum-Based Chemotherapy For Homologous Recombination Proficient, Advanced High-Grade Ovarian Cancer Patients: A Retrospective Study
2025
·
Elena Giudice
, Alessandra Giustozzi
, et al.
·
International Journal of Gynecological Cancer
Show more works
View as search
Works count:
6
Citation count:
27
H-index:
3
I10-index:
1
Year
Topic
Type